E-ISSN 2231-3206 | ISSN 2320-4672
 
2025, Vol: 15, Issue: 3
15 / 3Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

NJPPP Manuscript Submission Form

Original Research
Online Published: 02 Nov 2023
 


Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease

Sandhya Metta, Prasad D K V, Jayabalakrishnan S, Syamala Devi M, Joya Rani D.


Abstract
Background: Endothelial nitric oxide synthase (eNOS) enzyme plays a key role in maintaining optimal cardiovascular health. Furthermore, the literature review suggests the prominence eNOS gene polymorphisms in pathophysiology of ischemic heart disease (IHD).

Aim and Objectives: The aim of this study was to evaluate the association of eNOS gene intron 4a/b polymorphism with IHD in smokers.

Materials and Methods: Two hundred male patients presenting with IHD and 100 and 27 age-matched healthy males from the same demographic area were recruited for the study. Based on the history of smoking habit (≥20 pack years of smoking), the subjects were further categorized into non-smokers and smokers. All the subjects were analyzed for the eNOS gene 4a/b polymorphism and other relevant parameters.

Results: While studying the association of “aa” genotype with smoking in the patient group as well as in control group, there was no significant association observed between smoking behavior and genotype frequencies (for aa vs. ab+bb, odds ratio [OR] 1.5682, 95% confidence interval [CI] 0.6119–4.0191, P = 0.3457) in patient smokers versus patient non-smokers, OR 0.59, 95% CI 0.1349–2.581, P = 0.479 in control smokers versus control non-smokers.

Conclusion: Although genotype frequencies for eNOS 4 b/b, eNOS 4 a/b and eNOS 4 a/a and “a” allele frequency differed between IHD patients and controls, it was not statistically significant indicating “a” allele of eNOS intron 4 a/b variable number of tandem repeat polymorphism was not an independent predictor of IHD.

Key words: Endothelial Nitric Oxide Synthase Gene; Polymorphism; Smoking; Ischemic Heart Disease


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sandhya Metta
Articles by Prasad D K V
Articles by Jayabalakrishnan S
Articles by Syamala Devi M
Articles by Joya Rani D
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Metta S, V PDK, S J, M SD, D JR. Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease. Natl J Physiol Pharm Pharmacol. 2024; 14(6): 1047-1051. doi:10.5455/njppp.2023.13.10484202319102023

Web Style

Metta S, V PDK, S J, M SD, D JR. Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease. https://www.njppp.com/?mno=172161 [Access: April 17, 2025]. doi:10.5455/njppp.2023.13.10484202319102023

AMA (American Medical Association) Style

Metta S, V PDK, S J, M SD, D JR. Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease. Natl J Physiol Pharm Pharmacol. 2024; 14(6): 1047-1051. doi:10.5455/njppp.2023.13.10484202319102023


Vancouver/ICMJE Style

Metta S, V PDK, S J, M SD, D JR. Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease. Natl J Physiol Pharm Pharmacol. (2024), [cited April 17, 2025]; 14(6): 1047-1051. doi:10.5455/njppp.2023.13.10484202319102023


Harvard Style

Metta, S., V, . P. D. K., S, . J., M, . S. D. & D, . J. R. (2024) Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease. Natl J Physiol Pharm Pharmacol, 14 (6), 1047-1051. doi:10.5455/njppp.2023.13.10484202319102023


Turabian Style

Metta, Sandhya, Prasad D K V, Jayabalakrishnan S, Syamala Devi M, and Joya Rani D. 2024. Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease. National Journal of Physiology, Pharmacy and Pharmacology, 14 (6), 1047-1051. doi:10.5455/njppp.2023.13.10484202319102023


Chicago Style

Metta, Sandhya, Prasad D K V, Jayabalakrishnan S, Syamala Devi M, and Joya Rani D. "Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 1047-1051. doi:10.5455/njppp.2023.13.10484202319102023


MLA (The Modern Language Association) Style

Metta, Sandhya, Prasad D K V, Jayabalakrishnan S, Syamala Devi M, and Joya Rani D. "Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease." National Journal of Physiology, Pharmacy and Pharmacology 14.6 (2024), 1047-1051. Print. doi:10.5455/njppp.2023.13.10484202319102023


APA (American Psychological Association) Style

Metta, S., V, . P. D. K., S, . J., M, . S. D. & D, . J. R. (2024) Study of association of endothelial nitric oxide synthase gene intron 4a/b polymorphism in smokers with ischemic heart disease. National Journal of Physiology, Pharmacy and Pharmacology, 14 (6), 1047-1051. doi:10.5455/njppp.2023.13.10484202319102023


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

  National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

Eldaghayes Publisher

www.eldaghayes.com 
 

All correspondence should be addressed to:
Prof. Ibrahim Eldaghayes
Editor-in-Chief
National Journal of Physiology, Pharmacy and Pharmacology

Email: ibrahim.eldaghayes@vetmed.edu.ly